Innovation metrics in the context of cancer refer to the various ways in which advancements in cancer research, treatment, and prevention are measured. These metrics help in understanding the progress made, the effectiveness of new treatments, and the overall impact on patient outcomes. They include quantitative and qualitative measures, such as the number of new drug approvals, survival rates, and patient quality of life.
